United States: The Wide-Ranging Effects Of The Federal Circuit's Assault On Skinny Labels - Wilson Elser Moskowitz Edelman & Dicker LLP

The U.S. Federal Circuit Court of Appeals recently issued an opinion that effectively strips generic drug manufacturers of the ability to avoid inducement lawsuits through the use of skinny drug...